Advair

Type: Product
Name: Advair
First reported 32 mins ago - Updated 32 mins ago - 1 reports

Theravance Biopharma: Neglected Spinoff Targeting A Huge Underserved Market

Summary In a frothy environment for spinoffs, this one has been overlooked. Management is sticking with the spinoff. Clean balance sheet and a strong pipeline of opportunities.Theravance (NASDAQ: THRX ) is probably a familiar name to many of you. The ... [Published Seeking Alpha - 32 mins ago]
First reported 53 mins ago - Updated 53 mins ago - 1 reports

Analysts: Recent bouts of bad press could pose buying opportunity for GSK investors

It’s been a bad few months for GlaxoSmithKline, the British based company with North American headquarters in Research Triangle Park.Sales of its blockbuster asthma treatment Advair, made here in the Triangle, have been sinking, it’s second quarter results ... [Published Business First of Buffalo - 53 mins ago]
First reported 2 hours ago - Updated 2 hours ago - 1 reports

Advair, Symbicort charge Americans 5x what they charge Europeans

International pharmaceutical giants GlaxoSmithKline and AstraZeneca are charging Americans approximately five times what they charge the French for the popular asthma medicines Advair (Seretide in France) and Symbicort. Advair 500 goes for $73 (55 euros) ... [Published AMERICAblog News| A great nation deserves the t ... - 2 hours ago]
First reported Aug 18 2014 - Updated Aug 18 2014 - 1 reports

Sell-Side Bearish On GSK

Sell-side analysts like Goldman Sachs and Credit Suisse, have given GSK a Hold rating after the company missed second-quarter estimates, and lowered FY14 guidancePage 1 of 2Click Ticker to See live coverageGlaxoSmithKline plc (ADR) ( GSK ) has been facing ... [Published Bidness Etc - Aug 18 2014]
First reported Aug 14 2014 - Updated Aug 14 2014 - 1 reports

Why Would GSK Want InterMune?

GSK is rumored to be a bidder for InterMune. BidnessEtc explores how InterMune will fit into the pharma giant’s respiratory portfolioClick Ticker to See live coverageInterMune Inc ( ITMN ) is speculated to have been working with Goldman Sachs Group Inc ... [Published Bidness Etc - Aug 14 2014]
First reported Aug 05 2014 - Updated Aug 05 2014 - 5 reports

Express Scripts reinstates GSK's Advair, good news for Zebulon

For the past few months, drug giant GlaxoSmithKline has seen mostly just bad news about Advair, one of its all-time best sellers and manufactured in Zebulon.CEO Andrew Witty and GSK (NYSE: GSK) workers in the Triangle likely took the bit of good news ... [Published Triangle Business Journal - Aug 05 2014]
First reported Aug 04 2014 - Updated Aug 05 2014 - 8 reports

Neil Woodford: GlaxoSmithKline's troubles are only temporary

Renowned fund manager gives embattled drug giant a vote of confidence Veteran fund manager Neil Woodford has revealed that a "long conversation" with GlaxoSmithKline boss Sir Andrew Witty following a recent profits warning inspired confidence in the ... [Published Telegraph - Aug 05 2014]
First reported Jul 23 2014 - Updated Jul 24 2014 - 9 reports

Glaxo cuts year's outlook as Advair sales tumble

FROM STAFF AND WIRE SERVICESPosted:Thursday, July 24, 2014, 1:08 AMLondon-based drugmaker GlaxoSmithKline cut its forecast for the year, as sales of its best-selling asthma drug, Advair, continue to fall. Glaxo shares on the London Stock Exchange dropped ... [Published Philly.com - Jul 24 2014]
First reported Jul 23 2014 - Updated Jul 24 2014 - 12 reports

GLAXOSMITHKLINE : Patent end hits US drug sales

GlaxoSmithKline's (GSK's) second-quarter earnings missed analyst estimates as the UK's biggest pharmaceutical company said yesterday that sales of its respiratory drugs in the US remained sluggish. The company cut its forecast for the year. Profit excluding ... [Published 4 Traders - Jul 24 2014]
First reported Jul 23 2014 - Updated Jul 24 2014 - 15 reports

GSK profits warning takes toll

There WAS a 4.7% fall in GlaxoSmithKline shares yesterday as the pharma giant warned on earnings.The firm, which has a major manufacturing site at Montrose, revealed a 22% drop in core operating profits to £2.94 billion in the first six months of the ... [Published Tayside and Fife Courier - Jul 24 2014]
First reported Jul 23 2014 - Updated Jul 23 2014 - 7 reports

GSK cuts guidance as profits slide

UK pharma group battles to maintain its dominance of respiratory drugs market as sales of asthma medicine Advair face more pressure ... [Published FT.com - UK News - Jul 23 2014]
Entities: Advair, United Kingdom
First reported Jul 22 2014 - Updated Jul 22 2014 - 2 reports

BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors

RALEIGH, N.C.Mr. Bramlage is a veteran pharmaceutical industry executive with extensive experience in marketing, sales and other commercial functions. He is currently the Chief Executive Officer of Pearl Therapeutics, Inc., a development stage company ... [Published Bio-Medicine - Jul 22 2014]

Quotes

...As detailed in the Form 10 Theravance Biopharma was capitalized with $400 million of cash, "expected to fund operations through significant potential milestones over the following two to three years." So it's a well capitalized spin, not the typical leave them hanging in the wind spin - interesting?
googletag.defineSlot( "/1026291/3Amblog_2ndPostInsert_300', [300, 250], 'div-gpt-ad-1374256583012-0').addService(googletag.pubads());"
Kym Denny, Chief Executive Officer, commented: "We are delighted to have raised these funds through both existing and new shareholders, together with the tremendous support and encouragement we have received.  We are at an exciting inflection point for Retroscreen where having established and proven the h VIVO Human Challenge Model with our clients over the past couple of years, we now have the capability, capacity and funds to build on this and accelerate Retroscreen's own R&D programme, leveraging our h VIVO platform as a powerful tool in biomarker discovery and in the development of new disease models."
Bradd Pavur, a Glaxo spokesman, said the company takes "a thoughtful approach to pricing in all the countries in which we operate."

More Content

All (193) | News (164) | Reports (0) | Blogs (28) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Theravance Biopharma: Neglected Spinoff Targeti... [Published Seeking Alpha - 32 mins ago]
Analysts: Recent bouts of bad press could pose ... [Published Business First of Buffalo - 53 mins ago]
Advair, Symbicort charge Americans 5x what they... [Published AMERICAblog News| A great nation deserves the t ... - 2 hours ago]
How health insurance companies still cheat cust... [Published AMERICAblog News - Aug 20 2014]
Sell-Side Bearish On GSK [Published Bidness Etc - Aug 18 2014]
Why Would GSK Want InterMune? [Published Bidness Etc - Aug 14 2014]
Global asthma market to hit $18 billion by 2021... [Published Pharma Letter - Aug 14 2014]
InterMune Wild Ride Set to Pay Off With Drug: R... [Published Bloomberg - Aug 14 2014]
Conditional Placing to raise ?33.6 million [Published TrustNet - Aug 14 2014]
InterMune Surges On Takeover Reports [Published Bidness Etc - Aug 13 2014]
Cipla Q1 profit seen down 28%, revenue may jump... [Published Moneycontrol.com - Aug 13 2014]
Sarah Darer Littman: Doesn’t ‘truth in advertis... [Published Middletown Press - Aug 11 2014]
FT sources: RBS' Hampton top contender to succe... [Published FiercePharma - Aug 08 2014]
Viewpoints: Finding Drug Discounts In Canada; M... [Published Kaiser Health News - Aug 08 2014]
An O.C. couple do the math: Same drug is far ch... [Published Los Angeles Times - Aug 08 2014]
RBS chief Hampton lined up to become new chairm... [Published Mail Online UK - Aug 07 2014]
Mylan's (MYL) CEO Heather Bresch on Q2 2014 Res... [Published Seeking Alpha - Aug 07 2014]
GSK looking to bag RBS chairman Hampton [Published Telegraph - Aug 07 2014]
GSK Close To Luring RBS's Hampton As Chairman [Published LBC 97.3 - Aug 07 2014]
Most popular news headlines for Tuesday, August... [Published Cafepharma - Aug 06 2014]
Pfizer to Pay $35M in Organ Transplant Drug Set... [Published WBOC TV 16 - Aug 06 2014]
Latest news on Glaxo, Comcast, FCC and Google [Published Local Tech Wire - Aug 06 2014]
The formularies are here! Brace yourselves for ... [Published FiercePharma - Aug 06 2014]
Express Scripts reinstates GSK's Advair, good n... [Published Triangle Business Journal - Aug 05 2014]
GlaxoSmithKline’s Advair Win Undermined by Lack... [Published FirstWord Pharma - Aug 05 2014]
Note to Big Pharma: Discounts work. GSK price c... [Published FiercePharma - Aug 05 2014]
Latest news on Microsoft, Apple, GSK, municipal... [Published Local Tech Wire - Aug 05 2014]
Novo Nordisk more valuable than GlaxoSmithKline... [Published FiercePharma - Aug 05 2014]
Troubled GlaxoSmithKline Gets A Lift As Express... [Published BioSpace - Aug 05 2014]
Novo Nordisk A/S Leapfrogs GlaxoSmithKline To T... [Published BioSpace - Aug 05 2014]
1 2 3 4 5 6 7
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Advair, Symbicort charge Americans 5x what they... [Published AMERICAblog News| A great nation deserves the t ... - 2 hours ago]
International pharmaceutical giants GlaxoSmithKline and AstraZeneca are charging Americans approximately five times what they charge the French for the popular asthma medicines Advair (Seretide in France) and Symbicort. Advair 500 goes for $73 (55 euros) ...
How health insurance companies still cheat cust... [Published AMERICAblog News - Aug 20 2014]
One of the things that the Affordable Care Act (aka ACA, aka Obamacare) was meant to do was make sure that people with pre-existing medical problems could get health insurance. And that their insurance was  affordable.  But that may not be the case ...
It’s time for my annual medical tourism trip to... [Published AMERICAblog News| A great nation deserves the t ... - Jul 22 2014]
It’s that time again. When I act like I’m from a small village in a developing country and fly to western Europe in order to buy my asthma drugs that are 5x cheaper in France than they are America. Why are they cheaper in France?  Not because of government ...
It’s been a travel day with the dog [Published AMERICAblog News| A great nation deserves the t ... - Jul 16 2014]
Today was a travel day, as Sasha and I headed to Chicago to see my family for a week, then I’m off to France for my annual medical tourism / house-sitting for Chris and his wife Joelle. (As regular readers know, I buy my ridiculously overpriced American ...
Broker spotlight - Glaxo, BSkyB, Cairn, Dragon ... [Published Proactiveinvestors United Kingdom website - Jul 15 2014]
While the pharma sector has been buoyed by long-running takeover stories, first Pfizer’s failed move for AstraZeneca ( LON:AZN ) then AbbVie’s apparent capture of Shire ( LON:SHP ), UBS believes investors are expecting too much of GlaxoSmithKline ...
1 2 3 4 5 6
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.